Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers

References

• Gostin LO. Global regulatory strategies for tobacco control. JAMA. 2007;298:2057–2059.
   PubMed Web of Science ®Google Scholar
• Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929–940.
   PubMed Web of Science ®Google Scholar
• Jain A. Treating nicotine addiction. BMJ. 2003;327:1394–1395.
   PubMed Web of Science ®Google Scholar
• Moennikes O, Vanscheeuwijck PM, Friedrichs B, Anskeit E, Patskan GJ. Reduced toxicological activity of cigarette smoke by the addition of ammonia magnesium phosphate to the paper of an electrically heated cigarette: Subchronic inhalation toxicology. Inhal Toxicol. 2008;20:647–663.
   PubMed Web of Science ®Google Scholar
• Kuper H, Adami HO, Boffetta P. Tobacco use, cancer causation and public health impact. J Intern Med. 2002;251:455–466.
   PubMed Web of Science ®Google Scholar
• Haustein KO. What can we do in secondary prevention of cigarette smoking?. Eur J Cardiovasc Prev Rehabil. 2003;10:476–485.
   PubMedGoogle Scholar
• Benowitz NL, Hansson A, Jacob P. 3rd Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension. 2002;39:1107–1112.
   PubMed Web of Science ®Google Scholar
• Lavelle C, Birek C, Scott DA. Are nicotine replacement strategies to facilitate smoking cessation safe?. J Can Dent Assoc. 2003;69:592–597.
   PubMedGoogle Scholar
• Bondarev ML, Bondareva TS, Young R, Glennon RA. Behavioral and biochemical investigations of bupropion metabolites. Eur J Pharmacol. 2003;474:85–93.
   PubMed Web of Science ®Google Scholar
• Shrier M, Diaz JE, Tsarouhas N. Cardiotoxicity associated with bupropion overdose. Ann Emerg Med. 2000;35:100.
   PubMed Web of Science ®Google Scholar
• Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, et al. Bupropion: A review of its mechanism of antidepressant activity. J Clin Psychiatry. 1995;56:395–401.
   PubMed Web of Science ®Google Scholar
• Britton J, Jarvis MJ. Bupropion: A new treatment for smokers. Nicotine replacement treatment should also be available on the NHS. BMJ. 2000;321:65–66.
   PubMed Web of Science ®Google Scholar
• Gobbi G, Slater S, Boucher N, Debonnel G, Blier P. Neurochemical and psychotropic effects of bupropion in healthy male subjects. J Clin Psychopharmacol. 2003;23:233–239.
   PubMed Web of Science ®Google Scholar
• Glover ED, Glover PN, Payne TJ. Treating nicotine dependence. Am J Med Sci. 2003;326:183–186.
   PubMed Web of Science ®Google Scholar
• Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195–202.
   PubMed Web of Science ®Google Scholar
• Tønnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med. 2003;254:184–192.
   PubMed Web of Science ®Google Scholar
• Hughes JR. Motivating and helping smokers to stop smoking. J Gen Intern Med. 2003;18:1053–1057.
   PubMed Web of Science ®Google Scholar
• World Health Organization–International Society of Hypertension-Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17:151–183.
   PubMedGoogle Scholar
• Jones DW, Hall JE. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension. 2004;43:1–3.
   PubMed Web of Science ®Google Scholar
• Taylor DH Jr, Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92:990–996.
   PubMed Web of Science ®Google Scholar
• Nides M. Update on pharmacologic options for smoking cessation treatment. Am J Med. 2008;121:(4 Suppl 1):S20–31.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:1422–1431.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Porchet H, Sheiner L, Jacob P. 3rd Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clin Pharmacol Ther. 1988;44:23–28.
   PubMed Web of Science ®Google Scholar
• Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295:573–577.
   PubMed Web of Science ®Google Scholar
• Chalon S, Moreno H Jr, Benowitz NL, Hoffman BB, Blaschke TF. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther. 2000;67:391–397.
   PubMed Web of Science ®Google Scholar
• Marano G, Ramirez A, Mori I, Ferrari AU. Sympathectomy inhibits the vasoactive effects of nicotine in conscious rats. Cardiovasc Res. 1999;42:201–205.
   PubMed Web of Science ®Google Scholar
• Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994;90:248–253.
   PubMed Web of Science ®Google Scholar
• Moreno H Jr, Chalon S, Urae A, Tangphao O, Abiose AK, Hoffman BB, et al. Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol. 1998;275(3 Pt 2):H1040–H1045.
   PubMedGoogle Scholar
• Yugar-Toledo JC, Tanus-Santos JE, Sabha M, Sousa MG, Cittadino M, Tácito LH, et al. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest. 2004;125:823–830.
   PubMed Web of Science ®Google Scholar
• Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1998;287:435–439.
   PubMed Web of Science ®Google Scholar
• Mayhan WG, Sharpe GM, Anding P. Agonist-induced release of nitric oxide during acute exposure to nicotine. Life Sci. 1999;65:1829–1837.
   PubMed Web of Science ®Google Scholar
• Sabha M, Tanus-Santos JE, Toledo JC, Cittadino M, Rocha JC, Moreno H Jr. Transdermal nicotine mimics the smoking-induced endothelial dysfunction. Clin Pharmacol Ther. 2000;68:167–174.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P, 3rd Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther. 1982;221:368–372.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: Comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol. 1993;22:1159–1167.
   PubMed Web of Science ®Google Scholar
• Tanus-Santos JE, Toledo JC, Cittadino M, Sabha M, Rocha JC, Moreno H Jr. Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers. Am J Hypertens. 2001;147 Pt 1:610–614.
   PubMed Web of Science ®Google Scholar
• Parati G, Di Rienzo M, Bertinieri G, Pomidossi G, Casadei R, Groppelli A, et al. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension. 1988;12:214–222.
   PubMed Web of Science ®Google Scholar
• Tanus-Santos JE, Sampaio RC, Hyslop S, Franchini KG, Moreno H Jr. Endothelin ET(A) receptor antagonism attenuates the pressor effects of nicotine in rats. Eur J Pharmacol. 2000;396:33–37.
   PubMed Web of Science ®Google Scholar
• Fattinger K, Verotta D, Benowitz NL. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J Pharmacol Exp Ther. 1997;281:1238–1246.
   PubMed Web of Science ®Google Scholar
• Gerhardt U, Hans U, Hohage H. Influence of smoking on baroreceptor function: 24 h measurements. J Hypertens. 1999;17:941–946.
   PubMed Web of Science ®Google Scholar
• Mancia G, Groppelli A, Di Rienzo M, Castiglioni P, Parati G. Smoking impairs baroreflex sensitivity in humans. Am J Physiol. 1997;273.(3 Pt 2):H1555–H1560.
   PubMedGoogle Scholar
• Benowitz NL, Chan K, Denaro CP, Jacob P, 3rd . Stable isotope method for studying transdermal drug absorption: The nicotine patch. Clin Pharmacol Ther. 1991;50:286–293.
   PubMed Web of Science ®Google Scholar
• Fryer JD, Lukas RJ. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther. 1999;288:88–92.
   PubMed Web of Science ®Google Scholar
• Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry. 1991;148:512–516.
   PubMed Web of Science ®Google Scholar
• Richmond R, Zwar N. Review of bupropion for smoking cessation. Drug Alcohol Rev. 2003;22:203–220.
   PubMed Web of Science ®Google Scholar
• Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 1989;136 Pt 1:647–655.
   PubMed Web of Science ®Google Scholar
• Benowitz NL. Basic cardiovascular research and its implications for the medicinal use of nicotine. J Am Coll Cardiol. 2003;41:497–498.
   PubMed Web of Science ®Google Scholar
• Zeidler R, Albermann K, Lang S. Nicotine and apoptosis. Apoptosis. 2007;12:1927–1943.
   PubMed Web of Science ®Google Scholar